Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates

Completed · Not applicable

Conditions studied: Cardiovascular Diseases, Heart Diseases, Obesity

In brief

The purpose of this study is to determine if sibutramine will decrease post-cessation weight gain and cigarette smoking in overweight and obese smokers who quit smoking.

Key facts

Study ID

NCT00037752

Run by

University of Tennessee

People needed

436

Starts

2002-09-01

Expected to finish

2008-08-01

Last updated by the study team

2014-05-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• In good general health
• Body mass index greater than or equal to 25
• Currently smoke cigarettes

Where it is running

• University of Tennessee Health Science Center — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.